aluminum chloride has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Gao, J; Li, C; Liang, H; Wang, Q; Wu, Z; Zhang, C | 1 |
| Nolan, J; Oursler, MJ; Riggs, BL; Schütze, N; Spelsberg, TC | 1 |
2 other study(ies) available for aluminum chloride and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome.
Topics: Aluminum Chloride; Animals; Bone Resorption; Carrier Proteins; Cell Cycle Proteins; Cell Line; Femur; Male; Mice; Nicotinamide Mononucleotide; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; X-Ray Microtomography | 2019 |
Zeolite A inhibits osteoclast-mediated bone resorption in vitro.
Topics: Aluminum Chloride; Aluminum Compounds; Animals; Bone and Bones; Bone Resorption; Cathepsin B; Chickens; Chlorides; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Osteoclasts; Silicon Dioxide; Time Factors; Zeolites | 1995 |